MRNA Q1 2026 Earnings NarrowerThanExpected Loss Despite Revenue Absence CTO Q1 2026 Earnings Massive EPS Beat as Earnings Surge Past Estimates FSV Q1 2026 Earnings EPS Surpasses Estimates by Over 6 TRNR Q4 2025 Earnings Significant EPS Miss Reflects Ongoing Challenges QNTM Q4 2025 Earnings Loss Per Share Reported Shares Surge on Biotech Progress CANF Q4 2023 Earnings NarrowerthanExpected Loss Signals Operational Progress